A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Clinical trial NCT07013201 · RECRUITING
Trial details
- NCT number
- NCT07013201
- Sponsor
- LEO Pharma
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-11
- Primary completion
- 2026-12-14
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.